EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 28 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $67,700,000 | +25.6% | 853,285 | +10.8% | 0.01% | +9.1% |
| Q3 2016 | $53,891,000 | +237.4% | 769,869 | +87.0% | 0.01% | +175.0% |
| Q2 2016 | $15,971,000 | -3.6% | 411,735 | +0.6% | 0.00% | 0.0% |
| Q1 2016 | $16,574,000 | -52.5% | 409,234 | +4.1% | 0.00% | -50.0% |
| Q4 2015 | $34,856,000 | +130.2% | 393,097 | +92.2% | 0.01% | +100.0% |
| Q3 2015 | $15,139,000 | -8.9% | 204,499 | -0.5% | 0.00% | 0.0% |
| Q2 2015 | $16,615,000 | +4366.4% | 205,479 | +2215.0% | 0.00% | – |
| Q1 2015 | $372,000 | +644.0% | 8,876 | +174.7% | 0.00% | – |
| Q4 2014 | $50,000 | -95.0% | 3,231 | -95.9% | 0.00% | – |
| Q1 2014 | $1,003,000 | – | 78,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |